Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Adze Biotechnology | Oncolytic Immunotherapies for |
Description | Leading the Development of Systemically Deliverable Oncolytic Adze Biotechnology is developing a platform of immunotherapies that treat solid tumors and develop a robust anti-tumor immunity for |
Keywords | N/A |
WebSite | adzebiotech.com |
Host IP | 198.71.232.3 |
Location | United States |
Site | Rank |
US$2,322,904
Last updated: 2023-05-07 20:01:55
adzebiotech.com has Semrush global rank of 4,556,497. adzebiotech.com has an estimated worth of US$ 2,322,904, based on its estimated Ads revenue. adzebiotech.com receives approximately 268,028 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, adzebiotech.com is safe to visit. |
Purchase/Sale Value | US$2,322,904 |
Daily Ads Revenue | US$2,145 |
Monthly Ads Revenue | US$64,327 |
Yearly Ads Revenue | US$771,919 |
Daily Unique Visitors | 17,869 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
adzebiotech.com. | A | 7199 | IP: 198.71.232.3 |
adzebiotech.com. | NS | 14400 | NS Record: dns017.c.register.com. |
adzebiotech.com. | NS | 14400 | NS Record: dns170.b.register.com. |
adzebiotech.com. | NS | 14400 | NS Record: dns083.d.register.com. |
adzebiotech.com. | NS | 14400 | NS Record: dns243.a.register.com. |
adzebiotech.com. | MX | 14400 | MX Record: 10 alt4.aspmx.l.google.com. |
adzebiotech.com. | MX | 14400 | MX Record: 5 alt2.aspmx.l.google.com. |
adzebiotech.com. | MX | 14400 | MX Record: 10 alt3.aspmx.l.google.com. |
adzebiotech.com. | MX | 14400 | MX Record: 1 aspmx.l.google.com. |
adzebiotech.com. | MX | 14400 | MX Record: 5 alt1.aspmx.l.google.com. |
About Science Pipeline Partnering News Contact Main Menu Leading the Development of Systemically Deliverable Oncolytic Immunotherapies. Discover more Adze Biotechnology is developing a platform of immunotherapies that treat solid tumors and develop a robust anti-tumor immunity for patients. About Adze Biotechnology is engaged in the development of immunotherapies that treat tumors while engaging patient immune systems for durable responses. Learn More Science Our approach is based on our novel oncolytic backbone which enables systemic delivery to tumors previously inaccessible to these types of therapies. Learn More Pipeline We have a broad and growing pipeline of drugs which can deliver checkpoint inhibitors directly into tumors. Learn More Our immunotherapies turn cold tumors hot while delivering immune-modulating payloads to create durable anti-cancer responses. Our Vision Our vision is to build an immunotherapy company based on our differentiated oncolytic viral backbone. Our |
HTTP/1.1 301 Moved Permanently location: https://adzebiotech.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Thu, 28 Oct 2021 16:15:17 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.12.0 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Thu, 28 Oct 2021 16:15:17 GMT |
Domain Name: ADZEBIOTECH.COM Registry Domain ID: 2327267648_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2020-09-28T18:09:05Z Creation Date: 2018-10-29T16:39:52Z Registry Expiry Date: 2022-10-29T16:39:52Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTER.COM Name Server: DNS2.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T08:14:51Z <<< |